Response Comment on “Association between Interleukin-32 and Interleukin-17A Single Nucleotide Polymorphisms and Serum Levels with Polycystic Ovary Syndrome”
Abstract Abstract Abstract Abstract
2. Crosignani PG, Colombo M, Vegetti W, Somigliana E, Gessati A, Ragni G. Overweight and obese anovulatory patients with polycystic ovaries: parallel improvements in anthropometric indices, ovarian physiology and fertility rate induced by diet. Hum Reprod. 2003;18(9):1928-32.
3. Dağ ZÖ, Dilbaz B. Impact of obesity on infertility in women. J Turk Ger Gynecol Assoc. 2015;16(2):111-7.
4. Suturina LV, Atalyan AV, Darzhaev ZY, et al. Over weight and obesity prevalence in referral population of infertile women with polycystic ovary syndrome. Adv Obes Weight Manag Control. 2017;7(1):237-240.
5. Mahadevan S, Ali I. Is body mass index a good indicator of obesity? Int J Diabetes Develop Count. 2016;36(2):140-2.
6. Ozcaka O, Buduneli N, Ceyhan BO, Akcali A, Hannah V, Nile C, et al. Is interleukin-17 involved in the interaction between polycystic ovary syndrome and gingival inflammation? J Periodontol. 2013;84(12):1827-37.
7. Thomas EL, Frost G, Taylor-Robinson SD, Bell JD. Excess body fat in obese and normal-weight subjects. Nutr Res Rev. 2012;25(1):150-61.
8. Concato J, Hartigan JA. P values: from suggestion to superstition. Journal of investigative medicine : the official publication of the American Federation for Clinical Research. 2016;64(7):1166-71.
9. Lakens D. On the challenges of drawing conclusions from p-values just below 0.05. Peer J. 2015;3:e1142.
10. Amrhein V, Korner-Nievergelt F, Roth T. The earth is flat (p > 0.05): significance thresholds and the crisis of unreplicable research. Peer J. 2017;5:e3544.